Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.24%1.23B | -1.99%314.2M | -1.70%312.92M | 1.30%1.26B | -4.82%307.38M | 0.55%311.03M | 4.84%320.59M | 5.02%318.34M | 2.65%1.24B | 8.62%322.96M |
| Cost of revenue | ||||||||||
| Gross profit | -2.24%1.23B | -1.99%314.2M | -1.70%312.92M | 1.30%1.26B | -4.82%307.38M | 0.55%311.03M | 4.84%320.59M | 5.02%318.34M | 2.65%1.24B | 8.62%322.96M |
| Operating expense | 0.17%1.16B | 0.19%289.49M | -3.16%280.2M | 1.16%1.16B | 3.25%299.3M | -7.06%283.89M | 2.92%288.95M | 6.36%289.35M | 15.79%1.15B | 8.33%289.88M |
| Staff costs | -1.23%445.57M | ---- | ---- | 3.89%451.12M | ---- | ---- | ---- | ---- | 1.78%434.23M | ---- |
| Selling and administrative expenses | 3.73%412.31M | ---- | ---- | 15.88%397.49M | ---- | ---- | ---- | ---- | 14.02%343.01M | ---- |
| -General and administrative expense | 3.73%412.31M | ---- | ---- | 15.88%397.49M | ---- | ---- | ---- | ---- | 14.02%343.01M | ---- |
| Depreciation and amortization | -5.68%27.91M | ---- | ---- | 6.46%29.59M | ---- | ---- | ---- | ---- | 111.90%27.79M | ---- |
| -Depreciation | -5.68%27.91M | ---- | ---- | 6.46%29.59M | ---- | ---- | ---- | ---- | 111.90%27.79M | ---- |
| Other operating expenses | -2.00%277.63M | ---- | ---- | -17.43%283.3M | ---- | ---- | ---- | ---- | 36.71%343.11M | ---- |
| Operating profit | -31.37%65.78M | -21.90%24.71M | 12.86%32.72M | 3.00%95.85M | -75.56%8.09M | 601.78%27.14M | 26.30%31.63M | -6.66%28.99M | -57.24%93.06M | 11.27%33.09M |
| Net non-operating interest income (expenses) | 4,057.14%291K | 20,600.00%207K | 0.00%3K | 40.00%7K | 1K | 0.00%2K | 1K | 0.00%3K | -37.50%5K | 0 |
| Non-operating interest income | 4,057.14%291K | 20,600.00%207K | 0.00%3K | 40.00%7K | --1K | 0.00%2K | --1K | 0.00%3K | -37.50%5K | --0 |
| Net investment income | -1,550.00%-33K | -13K | -26K | 99.99%-2K | -73.62%-15.09M | 601.91%15.27M | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -197.47%-51.85M | |||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -63.72%-15.51M | -108.10%-9.48M | -9.18M | 0 | 65,610.67%116.97M | |||||
| Less:Other special charges | 69.03%15.51M | ---- | ---- | 107.85%9.18M | ---- | ---- | ---- | ---- | -35,119.46%-116.97M | ---- |
| Less:Write off | --0 | ---- | ---- | --298K | --0 | --0 | ---- | ---- | --0 | ---- |
| Other non-operating income (expenses) | 211K | 31K | 9,900.00%100K | 1K | 240K | 168K | ||||
| Income before tax | -41.26%50.74M | -20.44%24.93M | 13.11%32.8M | -39.74%86.37M | -100.97%-1.1M | 663.56%27.14M | 187.47%31.34M | 22.85%29M | -45.36%143.33M | 329.17%113.65M |
| Income tax | -25.09%20.43M | -13.85%9.67M | 17.98%11.33M | 34.11%27.27M | -101.72%-142K | 756.27%6.59M | 136.36%11.22M | 15.25%9.61M | -65.88%20.34M | 152.85%8.26M |
| Net income | -48.72%30.3M | -24.11%15.27M | 10.69%21.46M | -51.95%59.1M | -100.91%-958K | 639.14%20.55M | 226.95%20.12M | 27.00%19.39M | -39.32%123M | 353.98%105.39M |
| Net income continuous operations | -48.72%30.31M | -24.11%15.27M | 10.69%21.46M | -51.95%59.1M | -100.91%-958K | 639.14%20.55M | 226.89%20.12M | 27.01%19.39M | -39.32%123M | 353.98%105.39M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -48.72%30.3M | -24.11%15.27M | 10.69%21.46M | -51.95%59.1M | -100.91%-958K | 639.14%20.55M | 226.95%20.12M | 27.00%19.39M | -39.32%123M | 353.98%105.39M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -48.72%30.3M | -24.11%15.27M | 10.69%21.46M | -51.95%59.1M | -100.91%-958K | 639.14%20.55M | 226.95%20.12M | 27.00%19.39M | -39.32%123M | 353.98%105.39M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -48.74%10.21 | -24.04%5.15 | 10.55%7.23 | -51.95%19.92 | -100.90%-0.32 | 636.43%6.92 | 227.54%6.78 | 26.99%6.54 | -39.31%41.46 | 354.35%35.53 |
| Diluted earnings per share | -48.67%10.21 | -24.08%5.14 | 10.57%7.22 | -51.97%19.89 | -100.90%-0.32 | 635.66%6.91 | 227.05%6.77 | 27.04%6.53 | -39.26%41.41 | 354.29%35.48 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |